Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Henderson

Showing results (591-600 of 676) with videos related to

Pageof 68
Sort By:
Nature Immunology|October 19, 2010
IL-35-mediated induction of a potent regulatory T cell populationLauren W Collison, Vandana Chaturvedi, Abigail L Henderson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2019
The changing landscape of live kidney donation in the United States from 2005 to 2017Fawaz Al Ammary, Mary Grace Bowring, Allan B Massie, et al.
JMIR Mhealth and Uhealth|October 12, 2018
Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey StudyAnn K Eno, Alvin G Thomas, Jessica M Ruck, et al.
Journal of Medicinal Chemistry|October 30, 2014
Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitorJaclyn L Henderson, Bethany L Kormos, Matthew M Hayward, et al.
Transplantation Direct|October 3, 2019
Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney DonationKrista L Lentine, Courtenay M Holscher, Abhijit S Naik, et al.
JCO Oncology Practice|December 11, 2024
Qualitative Study of Health Care Team Perception of the Benefits and Limitations of Remote Symptom MonitoringEmma K Hendrix, Nicole L Henderson, Tanvi V Padalkar, et al.
Clinical Transplantation|June 14, 2019
Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providersAnn K Eno, Jessica M Ruck, Sarah E Van Pilsum Rasmussen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2019
Risk of ESKD in Older Live Kidney Donors with HypertensionFawaz Al Ammary, Xun Luo, Abimereki D Muzaale, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2024
Patient-Perceived Benefits and Limitations of Standard of Care Remote Symptom Monitoring During Cancer TreatmentCatherine S Smith, Nicole L Henderson, Emma K Hendrix, et al.
JCO Clinical Cancer Informatics|June 20, 2025
Patient Perspectives on Technological Barriers and Implementation Strategies Leveraged During a Real-World Remote Symptom Monitoring ProgramTanvi V Padalkar, Nicole L Henderson, D'Ambra N Dent, et al.
Pageof 68

Showing results (591-600 of 676) with videos related to

Sort By:
Pageof 68
Nature Immunology|October 19, 2010
IL-35-mediated induction of a potent regulatory T cell populationLauren W Collison, Vandana Chaturvedi, Abigail L Henderson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2019
The changing landscape of live kidney donation in the United States from 2005 to 2017Fawaz Al Ammary, Mary Grace Bowring, Allan B Massie, et al.
JMIR Mhealth and Uhealth|October 12, 2018
Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey StudyAnn K Eno, Alvin G Thomas, Jessica M Ruck, et al.
Journal of Medicinal Chemistry|October 30, 2014
Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitorJaclyn L Henderson, Bethany L Kormos, Matthew M Hayward, et al.
Transplantation Direct|October 3, 2019
Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney DonationKrista L Lentine, Courtenay M Holscher, Abhijit S Naik, et al.
JCO Oncology Practice|December 11, 2024
Qualitative Study of Health Care Team Perception of the Benefits and Limitations of Remote Symptom MonitoringEmma K Hendrix, Nicole L Henderson, Tanvi V Padalkar, et al.
Clinical Transplantation|June 14, 2019
Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providersAnn K Eno, Jessica M Ruck, Sarah E Van Pilsum Rasmussen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2019
Risk of ESKD in Older Live Kidney Donors with HypertensionFawaz Al Ammary, Xun Luo, Abimereki D Muzaale, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2024
Patient-Perceived Benefits and Limitations of Standard of Care Remote Symptom Monitoring During Cancer TreatmentCatherine S Smith, Nicole L Henderson, Emma K Hendrix, et al.
JCO Clinical Cancer Informatics|June 20, 2025
Patient Perspectives on Technological Barriers and Implementation Strategies Leveraged During a Real-World Remote Symptom Monitoring ProgramTanvi V Padalkar, Nicole L Henderson, D'Ambra N Dent, et al.
Pageof 68